Compare MKTX & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MKTX | TFX |
|---|---|---|
| Founded | 2000 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.6B |
| IPO Year | 2004 | 1994 |
| Metric | MKTX | TFX |
|---|---|---|
| Price | $193.33 | $120.85 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $204.44 | $140.25 |
| AVG Volume (30 Days) | 588.6K | ★ 953.4K |
| Earning Date | 05-11-2026 | 05-27-2026 |
| Dividend Yield | ★ 1.62% | 1.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.64 | N/A |
| Revenue | $397,471,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $10.06 | $85.12 |
| Revenue Next Year | $7.20 | $4.47 |
| P/E Ratio | $28.93 | ★ N/A |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $156.17 | $100.18 |
| 52 Week High | $232.84 | $143.32 |
| Indicator | MKTX | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 74.92 | 64.77 |
| Support Level | $177.38 | $117.58 |
| Resistance Level | $230.50 | $126.38 |
| Average True Range (ATR) | 4.93 | 5.03 |
| MACD | 1.87 | 1.80 |
| Stochastic Oscillator | 91.72 | 87.94 |
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.